SALEM, Ore. — The following statement was issued by Sheila McLean, a patient and the executive director of Patients For Affordable Drugs Now, after the Oregon Senate passed SB 764, which cracks down on abusive “pay-for-delay” deals between pharmaceutical manufacturers that delay generic competition and keep drug prices high:

“Oregonians have been suffering from high drug prices at the whim of Big Pharma for far too long. SB 764 would rightfully prohibit pharmaceutical companies from rigging the system to delay less expensive, generic medications from coming to market. This legislation would finally give Oregonians the access to less expensive prescriptions they desperately need. On behalf of patients, we urge the Oregon House to move quickly to pass this bill.”